A key component of GlobalSkin's mission is to build connections and opportunities for collaboration within the dermatology community. Bringing the patient perspective to the forefront is top of mind for GlobalSkin's Leadership Team and Board of Directors.   As part of GlobalSkin's reach and expertise, representatives have been invited to sit on several key committees, working groups and task forces. 

Other Committee Memberships Include:

  • RDI--WHO Collaborative Global Network for Rare Diseases Programme (CGN4RD)
    • In 2021, Rare Diseases International is launched CGN4RD Panel of Experts, an inclusive and global body composed of patient advocates, clinicians, researchers and health professionals from all six WHO regions.

      The Panel of Experts will provide input to help the WHO Collaborative Global Network Programme develop pilots that address the shared and specific challenges of people living with a rare disease around the world.

      GlobalSkin Programs Director Tammi Shipowick and Board Treasurer Marc Yale (International Pemphigus & Pemphigoid Foundation (IPPF), will participate on this panel.

  • Global Psoriasis Coalition  - A program of the International Federation of Psoriasis (IFPA), inspired by developments in the non-communicable diseases (NCD) policy agenda that calls on civil society to advocate for a people-centered and integrated response to psoriasis.

  • PeDRA Patient Advisory Committee  - The charge of the Pediatric Dermatology Research Alliance Patient Advisory Committee (PeDRA-PAC) is to inject the perspectives and priorities of patients and parents into PeDRA’s research activities, and to identify high-priority, cross-disease studies to be pursued by PeDRA investigators.

GlobalSkin is a Member of:

  • International Alliance of Patient Organizations (IAPO)
  • European Patients Forum (EPF)
  • Rare Disease International (RDI)
  • GlobalGenes
  • Coalition of Skin Diseases (CSD)
  • IFPA
  • World Patient Alliance